Heteroarylnaphthalene lactones as inhibitors of leukotriene bios

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

514468, 549299, A61K 3136, A61K 31365

Patent

active

054280605

ABSTRACT:
Compounds having the formula I: ##STR1## are inhibitors of leukotriene biosynthesis. These compounds are useful as anti-asthmatic, anti-allergic, anti-inflammatory, and cytoprotective agents. They are also useful in treating angina, cerebral spasm, glomerular nephritis, hepatitis, endotoxemia, uveitis, and allograft rejection and in preventing the formation of atherosclerotic plaques.

REFERENCES:
patent: 4486445 (1984-12-01), Patel et al.
patent: 4937373 (1990-06-01), Carson et al.
patent: 5227399 (1993-07-01), Young et al.
patent: 5252599 (1993-10-01), Girard et al.
The Merck Index, 11th ed., 5154, p. 829 (1989).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Heteroarylnaphthalene lactones as inhibitors of leukotriene bios does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Heteroarylnaphthalene lactones as inhibitors of leukotriene bios, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Heteroarylnaphthalene lactones as inhibitors of leukotriene bios will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-287921

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.